In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Q Therapeutics Inc.

www.qthera.com

Latest From Q Therapeutics Inc.

Execs On The Move, May 2014

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, September 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

Outdated Regulatory System Slows Technical Progress, Investigator Charges

Allowing other stem cell companies to use the protocol honed by Neuralstem instead of starting at square one would speed promising therapies to ALS patients and advance the field, researchers and patient advocates argued at FDA’s hearing on ALS drug development and regulation.

BioPharmaceutical Clinical Trials

Deals Shaping The Medical Industry, October 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Q Therapeutics Inc.
  • Senior Management
  • Steven J Borst, Pres., CEO & Chmn.
    James T Campanelli, PhD, VP, R&D
    Mahendra Rao, MD, PhD, Chief Strategy Officer
  • Contact Info
  • Q Therapeutics Inc.
    Phone: (801) 582-5400
    417 Wakara Way
    Ste. 3510
    Salt Lake City, UT 84108
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register